Royal Bank of Canada’s Biostage, Inc. Common Stock BSTG Stock Holding History

Royal Bank of Canada’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14	Closed	–	–	7326
2017 Q3	$0	Buy	+14	New	+$6	﹤0.01%	7264
2015 Q4	–	Sell	-1,000	Closed	-$1K	–	7031
2015 Q3	$1K	Hold	1,000	–	–	﹤0.01%	6554
2015 Q2	$1K	Hold	1,000	–	–	﹤0.01%	6512
2015 Q1	$3K	Hold	1,000	–	–	﹤0.01%	5879
2014 Q4	$3K	Hold	1,000	–	–	﹤0.01%	5935
2014 Q3	$8K	Buy	+1,000	New	+$8.18K	﹤0.01%	5557
2014 Q1	–	Sell	-1,500	Closed	-$7K	–	6292
2013 Q4	$7K	Buy	+1,500	New	+$7.01K	﹤0.01%	5546

Royal Bank of Canada's BSTG Position: Q4 2017 in Review

Royal Bank of Canada sold out of Biostage, Inc. Common Stock (BSTG) in Q4 2017, closing a stake of 14 shares.

Royal Bank of Canada first reported a position in BSTG in Q4 2013 and held it in 7 quarters. The position peaked at $8K in Q3 2014. 0 funds tracked by Wall St. Rank hold BSTG as of Q4 2017.

Royal Bank of Canada reported no remaining Biostage, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Royal Bank of Canada sold 14 Biostage, Inc. Common Stock shares in Q4 2017.
Royal Bank of Canada first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 7 quarters.
Royal Bank of Canada's Biostage, Inc. Common Stock position peaked at $8K in Q3 2014.
0 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q4 2017.

Based on Royal Bank of Canada's 13F filing for Q4 2017, filed 14 Feb 2018.